Drug
Remetinostat clinical trials
Also written SHP-141.
- studies test it
- 6
- open now
- 0
- in phase 3
- 0
- first study started
- 2011
How studies write it
Studies that test it under each name
Studies by the year they started
6 studies that test it; most in 2011 (1)
| Year | Studies |
|---|---|
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 2
Related medicines
As reviewed, each with the page that says it.
Studies
Open first, then newest update. How each study uses remetinostat is read from its arms, and is right about nine times in ten.
Testing it · 6
- Topical Remetinostat in Treating Patient With Cutaneous Basal Cell CancerCompletedPhase 2Kavita SarinNCT03180528Written as Remetinostat
- Topical Remetinostat Gel as Neoadjuvant Therapy in Patients With Squamous Cell Carcinoma (SCC)TerminatedPhase 2Kavita SarinNCT03875859Written as Remetinostat
- Safety and Efficacy Study of SHAPE Gel in Alopecia AreataStatus unknownPhase 2TetraLogic PharmaceuticalsNCT02636244Written as SHAPE Gel
- Efficacy, Safety and Tolerability Study of SHAPE in IA, IB or IIA Cutaneous T-cell LymphomaStatus unknownPhase 2TetraLogic PharmaceuticalsNCT02213861Written as SHAPE
- Safety, Pharmacodynamics (PD), Pharmacokinetics (PK) Study of SHP141 in 1A, 1B, or 2A Cutaneous T-Cell Lymphoma (CTCL)CompletedPhase 1TetraLogic PharmaceuticalsNCT01433731Written as SHAPE (SHP-141) 0.1% BID
- SHP-141C in Plaque Type PsoriasisCompletedPhase 1TetraLogic PharmaceuticalsNCT01646567Written as SHP-141C
Codes
What other systems call remetinostat · ClinicalTrials.gg INT001963
- UNII (FDA) 37NT056AT4REMETINOSTATConfirmed FDA, Wikidata
- Wikidata Q27256692remetinostatConfirmed FDA, Wikidata
- NCI Thesaurus C97513RemetinostatOne source FDA
- DrugBank DB14869One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 37NT056AT4 | REMETINOSTAT | Confirmed FDA, Wikidata |
| Wikidata | Q27256692 | remetinostat | Confirmed FDA, Wikidata |
| NCI Thesaurus | C97513 | Remetinostat | One source FDA |
| DrugBank | DB14869 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.